New publication about STOP HCC program
2.7-3.5 million people in the US have chronic HCV and roughly half don’t know it. This is particularly dangerous because HCV can develop into chronic liver disease and even liver cancer. A new publication from our group in the Annals of Internal Medicine describes the STOP HCC-HCV program to screen, manage, and treat HCV and its impact in six primary care health systems in South Texas that serve predominantly uninsured, Hispanic patients. We provide some lessons learned and highlight the need for driving resources towards settings and populations that shoulder the greatest burden of the disease.
View the article here.
Learn more about the STOP HCC-HCV program through our fact sheet and Implementation Overview page.
Follow the Annals of Internal Medicine on Facebook for more updates.